Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention (FACTPCI)
A Randomized Controlled Trial of Patients Undergoing Percutaneous Coronary Intervention Who Receive Ticagrelor and Fentanyl
Sponsor: The Guthrie Clinic
Terminated
Researcher stopped study due to slow accrual rate
Listed as NCT03476369, this PHASE4 trial focuses on Percutaneous Coronary Intervention and remains terminated or withdrawn. Sponsored by The Guthrie Clinic, it has been updated 16 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
16 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE4
-
Mar 2025 — Feb 2026 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Feb 2025 — Mar 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 11 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Feb 2023 — Feb 2024 [monthly]
Recruiting PHASE4
-
Jan 2022 — Feb 2023 [monthly]
Recruiting PHASE4
-
Mar 2021 — Jan 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jul 2019 — Mar 2020 [monthly]
Recruiting PHASE4
-
May 2019 — Jul 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Guthrie Clinic
For direct contact, visit the study record on ClinicalTrials.gov .